EDGAR Filing Documents for 0001193125-22-250274

Form 8-K - Current report:

SEC Accession No. 0001193125-22-250274

Filing Date

2022-09-23

Accepted

2022-09-23 17:20:48

Documents

Period of Report

2022-09-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d382544d8k.htm iXBRL	8-K	43133
2	EX-4.1	d382544dex41.htm	EX-4.1	63224
3	EX-10.1	d382544dex101.htm	EX-10.1	519256
4	EX-99.1	d382544dex991.htm	EX-99.1	12106
5	EX-99.2	d382544dex992.htm	EX-99.2	11295
9	GRAPHIC	g382544g0923085344068.jpg	GRAPHIC	5237
10	GRAPHIC	g382544g0924041601045.jpg	GRAPHIC	5237
	Complete submission text file	0001193125-22-250274.txt		943649

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	sppi-20220921.xsd	EX-101.SCH	2854
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sppi-20220921_lab.xml	EX-101.LAB	18758
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sppi-20220921_pre.xml	EX-101.PRE	11709
12	EXTRACTED XBRL INSTANCE DOCUMENT	d382544d8k_htm.xml	XML	3530

Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052

Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300

SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)